Navigation Links
SARS vaccine shows promise in Animal Testing

SARS, or severe acute respiratory syndrome, is a coronavirus. Similar viruses infect the pigs and other animals. It emerged in southern China in late 2002 and spread to more than two dozen countries on four continents before it was contained last summer. // More than 8,000 people worldwide were sickened, and at least 774 died.Civet cats and other mongoose-like animals that are sold in live food markets in southern China are suspected of spreading SARS to humans although the original source of the virus has not been determined.

Researchers say mice immunized with an experimental SARS vaccine were protected against the deadly respiratory disease Results from an accelerated federal research program show the vaccine prompted an immune response in the mice and dramatically reduced the level of the virus in the lungs of some mice.

However the results lead to mixed opinions , some researchers say more experiments are needed to determine if it will work in humans. Some scientists not connected with the study said the results were encouraging, but should not be overstated. No DNA vaccine has yet been shown to effectively treat any viral disease and the approach is still unproven compared to conventional vaccines.

Vaccines are normally made from dead or weakened viruses and work by mobilizing the body's immune system to build defenses by showing it what the targeted virus looks like. That approach is used every year, for example, to develop flu shots to combat emerging strains of influenza.

But the SARS vaccine was made from a small piece of genetic material from the virus called a plasmid. It biochemically locks onto a specific protein on the outer surface of the virus. This alerts the body's immune system to launch a counterattack against the invading virus.

Scientists tested two versions of the DNA vaccine in 15 mice over a six-week period. The vaccines differed in how much genetic material scientists removed from the origin al piece of DNA. Both worked, although one appeared to be more effective than the other.

Earlier this year, China announced plans to test on humans an experimental SARS vaccine that uses a killed virus. The vaccine had been shown to be effective in animal testing.
'"/>




Related medicine news :

1. New hope for cancer victims – will vaccine cure the deadly bug
2. New vaccine helps allergy and asthma patients
3. Man against HIV – new vaccine ready for human trials
4. New vaccine helps allergy and asthma patients
5. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
6. HIV did not arise from polio vaccine
7. Double impact vaccine
8. High Demand for a child vaccine
9. A new vaccine for leukemia
10. Shortage of MMR vaccine
11. Anthrax vaccine produced
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/5/2016)... ... , ... The event is being held on April 7, 2016 from 5:30 ... Over Parkinson’s will fund nearly $100,000 for research for the care and cure of ... and is the architect of this informative event to raise awareness and funds for ...
(Date:2/5/2016)... ... February 05, 2016 , ... Freed-Hardeman University President Joe ... signed a joint enrollment and degree completion agreement. The agreement, which begins ... degrees at FHU|Dickson. , The agreement allows students to be jointly admitted ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... franchises from across the country gathered at the La Valencia Hotel in San ... PROSHRED Chicago was named the year’s most outstanding franchise, walking away with ...
(Date:2/5/2016)... ... February 05, 2016 , ... Boar’s Head Brand®, one ... time for this weekend’s Big Game. Take the stress out of your party preparation ... your guests happy at every stage of the game. , “The key to hosting ...
(Date:2/5/2016)... ... February 05, 2016 , ... Stuart Bentkover, MD, FACS is ... to provide the most effective tattoo removal today, Dr. Bentkover is the only doctor ... by Cynosure, the PicoSure has been approved by the Food and Drug Administration (FDA) ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... 4, 2016  Omnicell, Inc. (NASDAQ: OMCL ), a ... healthcare systems, today announced results for its fiscal year ... --> --> GAAP results: Revenue for ... $5.1 million or 4.1% from the third quarter of ... fourth quarter of 2014. Revenue for the year ended ...
(Date:2/4/2016)... Feb. 4, 2016 In response to the opioid ... Deputy Commissioner for Medical Products and Tobacco, along with other ... the agency,s approach to opioid medications. The plan will focus ... patients in pain access to effective relief. ... , Re-examine the risk-benefit paradigm for opioids and ensure ...
(Date:2/4/2016)... -- --> --> ... Automated External Defibrillator (AED) Market by Product (Semi-Automated External ... Hospitals, Homecare & Nursing Homes) - Forecast to 2019", ... and segments the concerned market with an analysis and ... grow to about $367.0 million by 2019, at a ...
Breaking Medicine Technology: